×
S&P 500   3,831.39
DOW   30,967.82
QQQ   286.96
S&P 500   3,831.39
DOW   30,967.82
QQQ   286.96
S&P 500   3,831.39
DOW   30,967.82
QQQ   286.96
S&P 500   3,831.39
DOW   30,967.82
QQQ   286.96

7 Travel Stocks That Will Benefit as Covid Restrictions End - 1 of 7

 

#1 - Southwest Airlines (NYSE:LUV)

Southwest Airlines logo

The first on our list of travel stocks to buy is Southwest Airlines (NYSE:LUV). According to the research firm Kastle Systems, air traffic is now at about 80% of pre-pandemic levels. That wasn’t the case a year ago. Yet in mid-April of 2021, LUV stock had managed to push past its pre-pandemic stock price. Then the Delta and Omicron variants on top of logistic issues stemming from vaccine mandates pushed the stock below $40. However, the stock looks to have found a base of support.

A selling point for Southwest throughout the pandemic is that the airline does not rely on international travel. Plus, it’s less reliant on business travel which it still appears will take some time to recover.

Southwest’s financials appear to be in good shape although the company did suspend its dividend during the pandemic. However, at this point, it’s the forward guidance that investors care about more than anything. And right now, the company is projecting earnings and revenue to grow significantly over the next five years. If that’s the case any concern about the company’s high forward price/earnings ratio will be alleviated.

About Southwest Airlines

Southwest Airlines Co operates as a passenger airline company that provide scheduled air transportation services in the United States and near-international markets. As of December 31, 2021, the company operated a total fleet of 728 Boeing 737 aircrafts; and served 121 destinations in 42 states, the District of Columbia, and the Commonwealth of Puerto Rico, as well as 10 near-international countries, including Mexico, Jamaica, the Bahamas, Aruba, the Dominican Republic, Costa Rica, Belize, Cuba, the Cayman Islands, and Turks and Caicos.Read More 
Current Price
$36.51
Consensus Rating
Buy
Ratings Breakdown
9 Buy Ratings, 7 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$53.56 (46.7% Upside)




MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.